Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature

Neural transplantation of human fetal tissue for Huntington's disease (HD) is now entering the clinical arena. The safety of the procedure has now been demonstrated in a number of studies, although the efficacy of such an approach is still being investigated. Stringent but practicable screening...

Full description

Bibliographic Details
Main Authors: M. Farrington, T. G. Wreghitt, A. M. L. Lever, S. B. Dunnett, A. E. Rosser, R. A. Barker
Format: Article
Language:English
Published: SAGE Publishing 2006-04-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/000000006783981927
_version_ 1818342412308709376
author M. Farrington
T. G. Wreghitt
A. M. L. Lever
S. B. Dunnett
A. E. Rosser
R. A. Barker
author_facet M. Farrington
T. G. Wreghitt
A. M. L. Lever
S. B. Dunnett
A. E. Rosser
R. A. Barker
author_sort M. Farrington
collection DOAJ
description Neural transplantation of human fetal tissue for Huntington's disease (HD) is now entering the clinical arena. The safety of the procedure has now been demonstrated in a number of studies, although the efficacy of such an approach is still being investigated. Stringent but practicable screening of the donor tissue for potential pathogens is an essential prerequisite for successful implementation of any novel transplant program that uses human fetal tissue. In this article we summarize the UK-NEST protocol for the screening of human fetal tissue being grafted to patients with mild to moderate HD. We describe the results of microbiological screening of 87 potential tissue donors in a pilot study, and of the first four donor–recipient patients included in the UK-NEST series. The rationale for the adoption and interpretation of the various tests is described and our methodology is compared with those previously used by other centers. This article therefore presents a comprehensive, logical yet pragmatic screening program that could be employed in any clinical studies that use human fetal tissue for neurotransplantation.
first_indexed 2024-12-13T16:14:17Z
format Article
id doaj.art-af51b35d6a3c4a848df1e95dd41b6132
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-13T16:14:17Z
publishDate 2006-04-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-af51b35d6a3c4a848df1e95dd41b61322022-12-21T23:38:52ZengSAGE PublishingCell Transplantation0963-68971555-38922006-04-011510.3727/000000006783981927Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the LiteratureM. Farrington0T. G. Wreghitt1A. M. L. Lever2S. B. Dunnett3A. E. Rosser4R. A. Barker5Clinical Microbiology and Public Health Laboratory, Health Protection Agency & Addenbrooke's Hospital, Cambridge, UKClinical Microbiology and Public Health Laboratory, Health Protection Agency & Addenbrooke's Hospital, Cambridge, UKDepartment of Medicine, University of Cambridge, Cambridge, UKSchool of Biosciences, Cardiff University, Cardiff, UKSchool of Biosciences, Cardiff University, Cardiff, UKDepartment of Neurology, University of Cambridge, Cambridge, UKNeural transplantation of human fetal tissue for Huntington's disease (HD) is now entering the clinical arena. The safety of the procedure has now been demonstrated in a number of studies, although the efficacy of such an approach is still being investigated. Stringent but practicable screening of the donor tissue for potential pathogens is an essential prerequisite for successful implementation of any novel transplant program that uses human fetal tissue. In this article we summarize the UK-NEST protocol for the screening of human fetal tissue being grafted to patients with mild to moderate HD. We describe the results of microbiological screening of 87 potential tissue donors in a pilot study, and of the first four donor–recipient patients included in the UK-NEST series. The rationale for the adoption and interpretation of the various tests is described and our methodology is compared with those previously used by other centers. This article therefore presents a comprehensive, logical yet pragmatic screening program that could be employed in any clinical studies that use human fetal tissue for neurotransplantation.https://doi.org/10.3727/000000006783981927
spellingShingle M. Farrington
T. G. Wreghitt
A. M. L. Lever
S. B. Dunnett
A. E. Rosser
R. A. Barker
Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature
Cell Transplantation
title Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature
title_full Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature
title_fullStr Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature
title_full_unstemmed Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature
title_short Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature
title_sort neural transplantation in huntington s disease the nest uk donor tissue microbiological screening program and review of the literature
url https://doi.org/10.3727/000000006783981927
work_keys_str_mv AT mfarrington neuraltransplantationinhuntingtonsdiseasethenestukdonortissuemicrobiologicalscreeningprogramandreviewoftheliterature
AT tgwreghitt neuraltransplantationinhuntingtonsdiseasethenestukdonortissuemicrobiologicalscreeningprogramandreviewoftheliterature
AT amllever neuraltransplantationinhuntingtonsdiseasethenestukdonortissuemicrobiologicalscreeningprogramandreviewoftheliterature
AT sbdunnett neuraltransplantationinhuntingtonsdiseasethenestukdonortissuemicrobiologicalscreeningprogramandreviewoftheliterature
AT aerosser neuraltransplantationinhuntingtonsdiseasethenestukdonortissuemicrobiologicalscreeningprogramandreviewoftheliterature
AT rabarker neuraltransplantationinhuntingtonsdiseasethenestukdonortissuemicrobiologicalscreeningprogramandreviewoftheliterature